Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; water for injections; glycerol; medium chain triglycerides; sodium oleate; egg lecithin - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; egg lecithin; medium chain triglycerides; glycerol; sodium oleate; water for injections - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: water for injections; glycerol; medium chain triglycerides; sodium oleate; soya oil; egg lecithin - because of the difficulty in titrating small volumes, propofol-lipuro 2% should not be used in children aged from one month to 3 years.,induction of general anaesthesia in children and adults propofol-lipuro is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older.,maintenance of general anaesthesia in children and adults propofol-lipuro is a short acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older.,propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided.,propofol has no analgesic properties.,use for sedation during intensive care in adults propofol-lipuro may also be used in patients >16 years for sedation of ventilated patients receiving intensive care.,conscious sedation for surgical and diagnostic procedures propofol-lipuro may also be used for monitored conscious sedation for surgical and diagnostic procedures in,? propofol-lipuro 1%: adults and children aged one month and older. ? propofol-lipuro 2%: adults and children aged 3 years and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rocuronium bromide, quantity: 100 mg - injection, solution - excipient ingredients: acetic acid; sodium hydroxide; sodium chloride; water for injections; sodium acetate trihydrate - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - rocuronium bromide, quantity: 50 mg - injection, solution - excipient ingredients: sodium hydroxide; acetic acid; water for injections; sodium acetate trihydrate; sodium chloride - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - rocuronium bromide, quantity: 100 mg - injection, solution - excipient ingredients: sodium acetate; sodium chloride; glacial acetic acid; sodium hydroxide; water for injections - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - rocuronium bromide, quantity: 50 mg - injection, solution - excipient ingredients: sodium acetate; sodium chloride; glacial acetic acid; sodium hydroxide; water for injections - adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age. adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children. adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - propofol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: glycerol; medium chain triglycerides; soya oil; egg lecithin; sodium oleate; water for injections - induction of general anaesthesia in children and adults propofol-lipuro 1% is a short-acting intravenous anaesthetic agent suitable for induction of general anaesthesia in adults and children aged one month and older. maintenance of general anaesthesia in children and adults propofol-lipuro 1% is a short-acting intravenous anaesthetic agent suitable for maintenance of general anaesthesia in adults and children aged 3 years and older. propofol-lipuro 1% may also be used for maintenance of general anaesthesia in children aged from one month to 3 years for procedures not exceeding 60 minutes, unless alternative anaesthetic agents should be avoided. propofol-lipuro has no analgesic properties. sedation during intensive care in adults propofol-lipuro 1% may be used in adults for sedation of ventilated patients receiving intensive care. conscious sedation for surgical and diagnostic procedures in adults propofol-lipuro 1% may also be used in adults for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: glycerol; oleic acid; soya oil; sodium hydroxide; egg lecithin; water for injections - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - propofol, quantity: 10 mg/ml - injection, emulsion - excipient ingredients: soya oil; water for injections; egg lecithin; sodium hydroxide; oleic acid; glycerol - fresofol 1% is a short-acting intravenous anaesthetic agent suitable for the induction and maintenance of general anaesthesia in adults and children aged three years and older. fresofol 1% has no analgesic properties. although the safety and efficacy of fresofol 1% in paediatric day surgery have not been demonstrated, it may be a useful agent in this setting and its use should not be precluded. fresofol 1% may also be used in adults for the sedation of ventilated patients receiving intensive care, and for monitored conscious sedation for surgical and diagnostic procedures.